Several reports have identified elevated levels of corin and/or pro-ANP in the serum or plasma of women with preeclampsia at approximately 36 weeks gestation [27,30,43] or earlier as a predictive biomarker in high-risk women [44]. The gene discussed is CORIN; the disease is preeclampsia.